Facebook Pixel Code

Innova Captab Share Price

NSE
BSE

INNOVA CAPTAB

Smallcap | BSE

Here's the live share price of Innova Captab along with daily highs, lows, percentage changes and volume trends, and, all financial information.

₹1,180.00 Closed
1.32₹ 15.35
As on Sep 08, 2026, 04:01 PM IST
Intraday
1W
1M
3M
6M
YTD
1Y
3Y
5Y
10Y

Source: Dion Global

Innova Captab Price Performance

Today's LowToday's High
₹1,163.55₹1,181.80
₹1,180.00
52 Weeks' Low52 Weeks' High
₹608.25₹1,200.35
₹1,180.00
Open Price
₹1,173.20
Prev. Close
₹1,164.65
Volume
1,989

Source: Dion Global

Innova Captab Peer Comparision

Stock Performance
Ratio Performance
Name
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
Innova Captab
10.7621.8736.0374.1335.3629.3616.70
Sun Pharmaceutical Industries
-2.56-3.675.174.0719.0318.4919.34
Divi's Laboratories
4.4215.6646.8751.0358.8237.3313.47
Torrent Pharmaceuticals
0.080.9612.4813.5437.4838.3826.22
Zydus Lifesciences
-1.212.615.7526.5613.9622.3215.66
Cipla
-2.40-5.21-0.314.44-10.213.637.77
Laurus Labs
4.604.2638.5190.57117.1768.0024.25
Aurobindo Pharma
0.182.4316.1335.2062.0825.2217.79
Lupin
-1.77-7.16-6.24-8.248.4723.2316.55
Dr. Reddy's Laboratories
-1.67-0.51-9.74-10.49-7.911.043.23
Mankind Pharma
-2.29-5.42-2.236.65-10.589.4910.12
Glenmark Pharmaceuticals
0.537.9013.7217.0320.6947.2236.64
Biocon
-2.17-8.71-4.070.717.7713.782.00
Alkem Laboratories
-2.16-6.33-3.11-5.03-2.5312.766.68
Abbott India
-2.32-7.33-1.02-6.00-17.593.545.01
Anthem Biosciences
3.8812.3823.9845.3017.539.505.60
GlaxoSmithKline Pharmaceuticals
-2.1612.6534.1916.193.8726.0914.03
Ipca Laboratories
-1.7615.7018.4029.5147.8829.288.99
Gland Pharma
3.3011.2531.8376.3958.5720.52-5.60
Ajanta Pharma
2.632.4921.1222.6239.0127.6620.10

Source: Dion Global

Over the last one year, Innova Captab has gained 35.36% compared to peers like Sun Pharmaceutical Industries (19.03%), Divi's Laboratories (58.82%), Torrent Pharmaceuticals (37.48%). From a 5 year perspective, Innova Captab has outperformed peers relative to Sun Pharmaceutical Industries (19.34%) and Divi's Laboratories (13.47%).

Innova Captab Financials

Consolidated
Standalone
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Income Statement
Ratios

Source: Dion Global

Innova Captab Stock Technicals

Moving Average

DaySMAEMA
51,111.141,120
101,076.631,091.85
201,057.091,060.9
501,005.611,006.65
100928.13941.81
200813.61879.53

Source: Dion Global

Innova Captab Share Holding Pattern

In the latest quarter, Innova Captab remained same as its previous close in promoter holding, while DII stake decreased to 19.92%, FII holding rose to 0.34%, and public shareholding moved up to 28.84% compared to the previous quarter — reflecting a shift in investor sentiment across categories.

Innova Captab Stock Mutual Fund Holdings

Fund Name
No. Of Shares
% of AUM
Amount Invested(in ₹ crore)
17,88,9200.62175.04
16,29,9361.14159.48
6,30,0010.4661.64
2,61,8810.0925.62
1,64,5001.2716.1

Source: Dion Global

* Excluding Index & Arbitrage Funds

Innova Captab Corporate Actions

Date Time
Announcement
Sep 05, 2026, 01:43 AM IST ISTInnova Captab - Business Responsibility and Sustainability Reporting (BRSR)
Sep 05, 2026, 12:53 AM IST ISTInnova Captab - Reg. 34 (1) Annual Report.
Sep 05, 2026, 12:39 AM IST ISTInnova Captab - Notice Convening The 22Nd Annual General Meeting ('AGM') And Submission Of Integrated Annual Report Of The Co
Sep 03, 2026, 02:04 PM IST ISTInnova Captab - Board Meeting Outcome for Outcome Of The Board Meeting
Aug 22, 2026, 11:10 AM IST ISTInnova Captab - In Terms Of Regulations 30 Of The Listing Regulations, The Board Of Directors Of The Company Had Approved A B

Source: Dion Global

About Innova Captab

Innova Captab Ltd. is a Public Limited Listed company incorporated on 03/01/2005 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24246MH2005PLC150371 and registration number is 150371. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 1298.81 Cr. and Equity Capital is Rs. 57.23 Cr. for the Year ended 31/03/2026.

Source: Dion Global

Management

  • Mr. Manoj Kumar Lohariwala
    Chairman & Wholetime Director
  • Mr. Vinay Lohariwala
    Managing Director
  • Mr. Jayant Vasudeo Rao
    Whole Time Director
  • Mr. Archit Aggarwal
    Non Exe.Non Ind.Director
  • Mr. Sudhir Kumar Bassi
    Ind. Non-Executive Director
  • Mr. Shirish Gundopant Belapure
    Ind. Non-Executive Director
  • Ms. Priyanka Dixit
    Ind. Non-Executive Director
  • Mr. Mahender Korthiwada
    Ind. Non-Executive Director

FAQs on Innova Captab Share Price

What is the share price of Innova Captab?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Innova Captab is ₹1,180.00 as on Sep 08, 2026.

What kind of stock is Innova Captab?

The Innova Captab is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.

What is the Market Cap of Innova Captab?

The market cap of Innova Captab is ₹6,752.54 Cr as on Sep 08, 2026.

What are today's High and Low prices of Innova Captab?

Today’s highest and lowest price of Innova Captab are ₹1,181.80 and ₹1,163.55.

What are the 52 Week High and 52 Week Low of Innova Captab?

The 52-week high/low is the highest and lowest price at which Innova Captab stock has traded in the past 52-week or nearly a year. The 52-week high of Innova Captab is ₹1,200.35 and 52-week low of Innova Captab is ₹608.25 as on Sep 08, 2026.

How has the Innova Captab performed historically in terms of returns?

The Innova Captab has shown returns of 1.32% over the past day, 21.87% for the past month, 36.03% over 3 months, 35.36% over 1 year, 29.36% across 3 years, and 16.7% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Innova Captab?

P/E ratio of and PB ratio of Innova Captab are 43.84 and 5.95 on Sep 08, 2026. While the company gives a dividend yield of 0.00 per annum.

Source: Dion Global